We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
DELISTED
Light & Wonder
LNW
| $7.65M | 0.01% |
79,473
+43,249
| +119% | +$3.7M |
2016 Q1
37 quarters
|
|
627
Tetra Tech
TTEK
$8.91B
| $7.64M | 0.01% |
212,559
-258,267
| -55% | -$8.6M |
2019 Q2
24 quarters
|
|
628
Mondelez International
MDLZ
$80.4B
| $7.63M | 0.01% |
113,143
+34,178
| +43% | +$2.28M |
2013 Q2
48 quarters
|
|
629
Cushman & Wakefield Ltd
CWK
$2.73B
| $7.63M | 0.01% |
689,164
+295,615
| +75% | +$2.9M |
2021 Q3
15 quarters
|
|
630
Amalgamated Financial
AMAL
$1.41B
| $7.62M | 0.01% |
244,222
+1,639
| +0.7% | +$48K |
2022 Q2
12 quarters
|
|
631
OFG Bancorp
OFG
$2.2B
| $7.61M | 0.01% |
177,873
+32,113
| +22% | +$1.29M |
2013 Q3
47 quarters
|
|
632
Sterling Infrastructure
STRL
$13.7B
| $7.49M | 0.01% |
32,461
+5,406
| +20% | +$944K |
2022 Q4
10 quarters
|
|
633
Stoneridge
SRI
$173M
| $7.48M | 0.01% |
1,062,490
+356,143
| +50% | +$1.74M |
2024 Q4
2 quarters
|
|
634
Newmark Group
NMRK
$2.16B
| $7.48M | 0.01% |
615,463
+16,304
| +3% | +$182K |
2018 Q2
28 quarters
|
|
635
iRhythm Holdings
IRTC
$3.6B
| $7.46M | 0.01% |
+48,424
| New | +$6.26M |
2025 Q2
0 quarters
|
|
636
Acuity Brands
AYI
$9.04B
| $7.34M | 0.01% |
24,601
+4,040
| +20% | +$1.05M |
2017 Q4
30 quarters
|
|
637
Twilio
TWLO
$42B
| $7.3M | 0.01% |
58,717
-2,744
| -4% | -$292K |
2024 Q1
5 quarters
|
|
638
Cameco
CCJ
$36.2B
| $7.3M | 0.01% |
98,284
-38,056
| -28% | -$2.03M |
2023 Q3
7 quarters
|
|
639
Xenon Pharmaceuticals
XENE
$3.32B
| $7.28M | 0.01% |
232,500
| – | – |
2023 Q4
6 quarters
|
|
640
American Integrity Insurance
AII
$543M
| $7.23M | 0.01% |
+393,334
| New | +$6.64M |
2025 Q2
0 quarters
|
|
641
Prothena Corp
PRTA
$436M
| $7.17M | 0.01% |
1,181,087
+634,832
| +116% | +$4.76M |
2024 Q2
4 quarters
|
|
642
Lowe's Companies
LOW
$110B
| $7.09M | 0.01% |
31,936
-20,857
| -40% | -$4.65M |
2013 Q2
48 quarters
|
|
643
Analog Devices
ADI
$196B
| $7.02M | 0.01% |
29,511
-2,157
| -7% | -$449K |
2013 Q2
48 quarters
|
|
644
Revolve Group
RVLV
$1.65B
| $6.97M | 0.01% |
347,664
+102,573
| +42% | +$2.08M |
2019 Q2
24 quarters
|
|
645
BrightSpire Capital
BRSP
$480M
| $6.97M | 0.01% |
1,380,325
+8,798
| +0.6% | +$44.4K |
2023 Q2
8 quarters
|
|
646
Fastenal
FAST
$57.8B
| $6.96M | 0.01% |
165,750
+163,502
| +7,273% | +$6.63M |
2013 Q2
48 quarters
|
|
647
DELISTED
TruBridge
TBRG
| $6.92M | 0.01% |
295,386
-165,406
| -36% | -$4.06M |
2023 Q4
6 quarters
|
|
648
Adtran
ADTN
$532M
| $6.89M | 0.01% |
767,743
+5,224
| +0.7% | +$41.7K |
2023 Q4
6 quarters
|
|
649
Viasat
VSAT
$8.47B
| $6.88M | 0.01% |
470,906
+468,782
| +22,071% | +$4.74M |
2024 Q4
2 quarters
|
|
650
Wendy's
WEN
$1.28B
| $6.86M | 0.01% |
600,686
-24,003
| -4% | -$293K |
2013 Q2
48 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.